2 Coronavirus Stocks to Avoid This Month

Inovio Pharmaceuticals (NASDAQ: INO) and Gilead Sciences (NASDAQ: GILD) are major competitors in the growing market for coronavirus products, making both tantalizing stock picks. Inovio's stock has soared this year thanks to its INO-4800 coronavirus vaccine project, which has so far proven effective at producing immunity in primates. In contrast, Gilead's stock has consistently struggled despite the commercialization of its antiviral drug, remdesivir, which may be effective at helping patients recover from COVID-19.